← Leaderboards
Ralph H Mattern
Telios Pharmaceuticals, Inc.
$750,000
Attributed
$750,000
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$750,000 · 1
By mechanism
R44$750,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Angiogenesis Inhibitors”
- Walter John Curran · Thomas Jefferson University$26,641,549
- David Heimbrook · Leidos Biomedical Research, Inc.$24,469,358
- David R Harder · Medical College Of Wisconsin$16,163,720
- Elizabeth Marion Jaffee · Johns Hopkins University$12,679,276
- Garrett M Brodeur · Children'S Hospital Of Philadelphia$12,442,187
- Erwin G Van Meir · University Of Alabama At Birmingham$11,726,130
Research focus
Angiogenesis InhibitorsBiomimeticsDiabetes Mellitus TherapyDiabetic RetinopathyDrug Design /Synthesis /ProductionEye AgentEye Disorder ChemotherapyIntegrinsLaboratory MouseLaboratory RabbitNuclear Magnetic Resonance SpectroscopyPeptide Chemical Synthesis